Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]

View source ↗

Summary

Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed study addressing Hepa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• INFANRIX HEXAVAC
• Infanrix Hexa (DTPa-HBV-IPV/Hib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Poliomyelitis | Phase 4 | Status: COMPLETED